Turacoz Group Analysis:
Founded in 2014 and headquartered in The Netherlands, Turacoz Group is an ISO Certified 9001:2008 medical communication company with a strong presence in India. The company boasts a notable roster of over 30 premium global pharmaceutical clients across Asia Pacific, Europe, Middle-East, and Latin America.
Their team of medical writers and editors, with an average experience of 5 to 8 years, offers expertise in developing scientific content across various therapeutic areas. Furthermore, the inclusion of proofreaders, copy editors, bio-statisticians, and SAS programmers enhances the quality of their content and provides comprehensive support throughout the product life cycle.
What distinguishes Turacoz from its counterparts is its unwavering commitment to each project, personalized attention from senior team members, and a "never say die" attitude. Additionally, the company prides itself on the advantages of being a small organization with a back-end office in India, including cost-effectiveness, rapid response time, and high-quality output.
Offering services such as clinical trials related documents, non-interventional studies, publication support, marketing solutions, and training services, Turacoz presents a comprehensive suite tailored to the pharmaceutical industry's needs.
While specific details about the company's investment history are currently unavailable, given its strong foothold in the pharmaceutical industry and unique approach to medical communication, Turacoz could be an intriguing prospect for potential investors seeking opportunities in the evolving healthcare and pharmaceutical landscape. With its diverse portfolio and personalized approach, Turacoz exhibits the potential for future growth and success within the pharmaceutical industry.
There is no investment information
No recent news or press coverage available for Turacoz Group .